MAXRX
DEAD

Serial Number

98866610

Owner

MaxRx, LLC

Attorney

Kathryn Yoches

First Use Date

Nov 12, 2025

Filing Date

Nov 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MAXRX Trademark

Serial Number: 98866610

MAXRX is a trademark filed by MaxRx, LLC on November 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

MaxRx, LLC

1101 Brickell Ave, South Tower, 8th FL
Miami, FL 33131

Entity Type: 16

Trademark Details

Filing Date

November 21, 2024

Registration Date

Not Registered

First Use Anywhere

November 12, 2025

First Use in Commerce

November 12, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.

Pharmaceutical services, namely, processing and fulfilling online prescription orders; online retail store services featuring over-the counter medications and medical supplies; specialized retail pharmacy services for patients with particular medical conditions; referral services provided via a secure online platform for purposes of bringing together patients and healthcare providers; medical and physician referral services; administration of a subscription based membership community for the purpose of obtaining information about and ordering prescription and over the counter medications at a discounted rate; medical data management services, namely, electronic data collection and storage for subsequent submission for business purposes in the fields of medicine and healthcare; Administration of a discount program for enabling participants to obtain discounts on goods and services through use of a discount membership card; pharmaceutical discount program, namely, administration of a discount program for enabling participants to obtain discounts when ordering prescriptions and over the counter medications

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 25, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 25, 2026 ABN2
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 13, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 13, 2026 REAP
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Jan 12, 2026 GAUN
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Jan 12, 2026 GAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Jan 12, 2026 NAUD
USE AMENDMENT ACCEPTED
Jan 12, 2026 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Dec 4, 2025 AUPC
USE AMENDMENT FILED
Dec 4, 2025 IUAF
TEAS AMENDMENT OF USE RECEIVED
Dec 4, 2025 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 9, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 9, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 9, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 2, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 2, 2025 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2025 CNRT
ASSIGNED TO EXAMINER
May 15, 2025 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 25, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 25, 2024 PARI
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 25, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 25, 2024 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2024 NWOS
NEW APPLICATION ENTERED
Nov 22, 2024 NWAP